Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 17
253
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Anti-HIV crotocascarin ω from Kenyan Croton dichogamus

ORCID Icon, , , , & ORCID Icon
Pages 2809-2816 | Received 02 Mar 2022, Accepted 06 Oct 2022, Published online: 24 Oct 2022
 

Abstract

An anti-HIV methanol-soluble fraction of a 1:1 CH2Cl2:CH3OH extract of twigs of a Kenyan Croton dichogamus yielded seven compounds, the new crotocascarin ω (1), the known β-oplopanone (2), dihydroconiferyl acetate (3), 3’(4’’-hydroxyphenyl)-propyl benzoate (4), lupeol, sitosterol and stigmasterol. Crotocascarin ω (90%) inhibited HIV-1 replication with an IC50 value of 5.3 nM, and the compound was cytotoxic towards MT-4 cells presenting an IC50 value of 84 µM. In silico modelling showed that the anti-HIV activity for compound 1 could be through the HIV-1 protease inhibition.

Graphical Abstract

Acknowledgments

EMT acknowledges University of Nairobi, Kenya Medical Research Institute and the Institute of Primate Research for their support toward the successful completion of the research work.

Institutional review board statement

The collection of the plant was performed after obtaining the required ethical approval from the Kenyatta National Hospital-University of Nairobi Ethics and Research Committee (KNH-UON ERC), approval number P992/12/2019.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was funded by United States International University- Africa Internal grant no. 10-2854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.